Schedule 13G ownership disclosure
CORREVIO PHARMA CORP
Security class unavailable · CUSIP: 22026V105
Event date: 2019-03-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 4,788,032
- Percent of class
- 12.2100%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001085146-19-001081
- Form type
- SC 13G
- Filer
- Correvio Pharma Corp.
- CIK
- CIK 1036141
- Filed
- Apr 05, 2019
- Reporting period
- Mar 31, 2019
- Description
- Schedule 13G beneficial ownership